Stocks
Elanco Animal Health Financial Statements (ELAN) |
||||||||||
| Elanco Animal Healthsmart-lab.ru | % | 2023Q1 | 2023Q2 | 2023Q3 | 2023Q4 | 2024Q1 | LTM ? | |||
|---|---|---|---|---|---|---|---|---|---|---|
| Report date | 09.05.2023 | 07.08.2023 | 07.11.2023 | 26.02.2024 | 08.05.2024 | 08.05.2024 | ||||
| Currency | USD | USD | USD | USD | USD | USD | ||||
| Financial report URL | ||||||||||
| Revenue, bln rub | ? | 1 257 | 1 057 | 1 068 | 1 035 | 1 205 | 4 365 | |||
| Operating Income, bln rub | 212.0 | 53.0 | 42.0 | -24.0 | 133.0 | 204.0 | ||||
| EBITDA, bln rub | ? | 346.0 | 166.0 | 173.0 | 147.0 | 290.0 | 776.0 | |||
| Net profit, bln rub | ? | 103.0 | -97.0 | -1 096 | -141.0 | 32.0 | -1 302 | |||
| OCF, bln rub | ? | -145.0 | 61.0 | 198.0 | 157.0 | 2.00 | 418.0 | |||
| CAPEX, bln rub | ? | 38.0 | 42.0 | 33.0 | 41.0 | 24.0 | 140.0 | |||
| FCF, bln rub | ? | -183.0 | 19.0 | 165.0 | 116.0 | -22.0 | 278.0 | |||
| Dividend payout, bln rub | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | ||||
| Ordinary share dividend yield, % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | ||||
| Dividend payout ratio, % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0 | ||||
| OPEX, bln rub | 542.0 | 570.0 | 539.0 | 509.0 | 557.0 | 2 175 | ||||
| Cost of production, bln rub | 494.0 | 434.0 | 487.0 | 516.0 | 515.0 | 1 952 | ||||
| R&D, bln rub | 81.0 | 81.0 | 86.0 | 79.0 | 87.0 | 333.0 | ||||
| Interest expenses, bln rub | 64.0 | 74.0 | 72.0 | 67.0 | 66.0 | 279.0 | ||||
| Assets, bln rub | 15 769 | 15 796 | 14 344 | 14 362 | 14 019 | 14 019 | ||||
| Net Assets, bln rub | ? | 7 480 | 7 420 | 6 134 | 6 223 | 6 056 | 6 056 | |||
| Debt, bln rub | 6 020 | 6 062 | 5 909 | 5 774 | 5 765 | 5 765 | ||||
| Cash, bln rub | 318.0 | 367.0 | 369.0 | 352.0 | 345.0 | 345.0 | ||||
| Net debt, bln rub | 5 702 | 5 695 | 5 540 | 5 422 | 5 420 | 5 420 | ||||
| Ordinary share price, rub | 9.40 | 10.1 | 11.2 | 14.9 | 16.3 | 9.38 | ||||
| Number of ordinary shares, mln | 491.1 | 492.6 | 492.7 | 492.8 | 493.2 | 493.2 | ||||
| Market cap, bln rub | 4 616 | 4 956 | 5 538 | 7 343 | 8 029 | 4 626 | ||||
| EV, bln rub | ? | 10 318 | 10 651 | 11 078 | 12 765 | 13 449 | 10 046 | |||
| Book value, bln rub | -3 372 | -3 298 | -3 243 | -3 365 | -2 618 | -2 618 | ||||
| EPS, rub | ? | 0.21 | -0.20 | -2.22 | -0.29 | 0.06 | -2.64 | |||
| FCF/share, rub | -0.37 | 0.04 | 0.33 | 0.24 | -0.04 | 0.56 | ||||
| BV/share, rub | -6.87 | -6.70 | -6.58 | -6.83 | -5.31 | -5.31 | ||||
| EBITDA margin, % | ? | 27.5% | 15.7% | 16.2% | 14.2% | 24.1% | 17.8% | |||
| Net margin, % | ? | 8.19% | -9.18% | -102.6% | -13.6% | 2.66% | -29.8% | |||
| FCF yield, % | ? | 3.75% | -1.76% | -1.17% | 1.59% | 3.46% | 6.01% | |||
| ROE, % | ? | -0.29% | -1.31% | -18.7% | -19.8% | -21.5% | -21.5% | |||
| ROA, % | ? | -0.14% | -0.61% | -7.98% | -8.57% | -9.29% | -9.29% | |||
| P/E | ? | -209.8 | -51.1 | -4.84 | -5.96 | -6.17 | -3.55 | |||
| P/FCF | 26.7 | -57.0 | -85.2 | 62.8 | 28.9 | 16.6 | ||||
| P/S | ? | 1.04 | 1.14 | 1.27 | 1.66 | 1.84 | 1.06 | |||
| P/BV | ? | -1.37 | -1.50 | -1.71 | -2.18 | -3.07 | -1.77 | |||
| EV/EBITDA | ? | 10.7 | 12.4 | 13.5 | 15.3 | 17.3 | 12.9 | |||
| Debt/EBITDA | 5.93 | 6.63 | 6.75 | 6.52 | 6.98 | 6.98 | ||||
| R&D/CAPEX, % | 213.2% | 192.9% | 260.6% | 192.7% | 362.5% | 237.9% | ||||
| CAPEX/Revenue, % | 3.02% | 3.97% | 3.09% | 3.96% | 1.99% | 3.21% | ||||
| Elanco Animal Health shareholders | ||||||||||
